Ashland Inc. (ASH)
NYSE: ASH · Real-Time Price · USD
85.32
+0.50 (0.59%)
Nov 4, 2024, 4:00 PM EST - Market closed
Ashland Revenue
Ashland had revenue of $544.00M in the quarter ending June 30, 2024, a decrease of -0.37%. This brings the company's revenue in the last twelve months to $2.11B, down -8.59% year-over-year. In the fiscal year ending September 30, 2023, Ashland had annual revenue of $2.19B, down -8.36%.
Revenue (ttm)
$2.11B
Revenue Growth
-8.59%
P/S Ratio
2.04
Revenue / Employee
$554,737
Employees
3,800
Market Cap
4.17B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2023 | 2.19B | -200.00M | -8.36% |
Sep 30, 2022 | 2.39B | 280.00M | 13.26% |
Sep 30, 2021 | 2.11B | 95.00M | 4.71% |
Sep 30, 2020 | 2.02B | -132.00M | -6.15% |
Sep 30, 2019 | 2.15B | -441.00M | -17.03% |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Sep 30, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Olin Corporation | 6.48B |
Huntsman | 5.95B |
H.B. Fuller Company | 3.55B |
The Scotts Miracle-Gro Company | 3.51B |
Avient | 3.21B |
NewMarket | 2.78B |
B2Gold | 1.94B |
Grupo Simec, S.A.B. de C.V. | 1.71B |
ASH News
- 7 days ago - Ashland sets date for fourth-quarter fiscal 2024 earnings release and conference call webcast - GlobeNewsWire
- 6 weeks ago - D.A. Davidson Acts as Exclusive Financial Advisor to Turnspire Capital Partners for Debt Financing in Support of Turnspire's Acquisition of Pharmachem - Business Wire
- 2 months ago - Ashland completes sale of nutraceuticals business - GlobeNewsWire
- 2 months ago - Pharmachem Innovations Launches as a Leading Independent Provider of Nutraceuticals Products and Solutions - Business Wire
- 2 months ago - Turnspire Capital Partners Completes Acquisition of Pharmachem from Ashland - Business Wire
- 3 months ago - Ashland board authorizes quarterly dividend - GlobeNewsWire
- 3 months ago - Ashland Inc. (ASH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Ashland reports financial results1 for third quarter fiscal 2024, issues outlook for fourth quarter and full-year fiscal 2024 - GlobeNewsWire